PureTech Historical Cash Flow
| PRTC Stock | USD 22.21 1.18 5.04% |
Analysis of PureTech Health cash flow over time is an excellent tool to project PureTech Health PLC future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Cashflows From Financing Activities of 101.5 M or Depreciation of 3.9 M as it is a great indicator of PureTech Health ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining PureTech Health PLC latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether PureTech Health PLC is a good buy for the upcoming year.
PureTech |
About PureTech Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in PureTech balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which PureTech's non-liquid assets can be easily converted into cash.
PureTech Health Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Depreciation
Depreciation indicates how much of PureTech Health PLC value has been used up. For tax purposes PureTech Health can deduct the cost of the tangible assets it purchases as business expenses. However, PureTech Health PLC must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Capital Expenditures
Capital Expenditures are funds used by PureTech Health PLC to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of PureTech Health operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Change To Inventory
The increase or decrease in the amount of inventory a company has over a certain period.Most accounts from PureTech Health's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into PureTech Health PLC current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PureTech Health PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. At present, PureTech Health's Change In Working Capital is projected to increase significantly based on the last few years of reporting. The current year's Other Cashflows From Financing Activities is expected to grow to about 101.5 M, whereas Sale Purchase Of Stock is projected to grow to (18.7 M).
| 2022 | 2023 | 2024 (projected) | Capital Expenditures | 2.2M | 245K | 232.8K | Dividends Paid | 393K | 452.0K | 311.7K |
PureTech Health cash flow statement Correlations
Click cells to compare fundamentals
PureTech Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
PureTech Health cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Sale Purchase Of Stock | 1.2M | (12.9M) | (13.3M) | (26.5M) | (19.7M) | (18.7M) | |
| Change In Cash | 15.3M | 271.5M | 61.8M | (315.8M) | 41.2M | 43.3M | |
| Stock Based Compensation | 14.5M | 10.7M | 14.0M | 14.7M | 4.4M | 4.2M | |
| Free Cash Flow | (110.7M) | (137.3M) | (163.9M) | (181.0M) | (106.2M) | (111.5M) | |
| Change In Working Capital | 15.0M | (8.5M) | 861K | 15.9M | 17.5M | 18.4M | |
| Begin Period Cash Flow | 117.1M | 132.4M | 403.9M | 465.7M | 149.9M | 149.5M | |
| Other Cashflows From Financing Activities | (1.3M) | 38.7M | 33.5M | (4.1M) | 96.6M | 101.5M | |
| Depreciation | 6.7M | 6.6M | 7.3M | 8.9M | 4.9M | 3.9M | |
| Other Non Cash Items | 46.2M | 6.1M | (5.1M) | (111.1M) | (67.1M) | (63.7M) | |
| Dividends Paid | 1.1M | 112K | 367K | 393K | 452.0K | 311.7K | |
| Capital Expenditures | 12.5M | 5.4M | 5.7M | 2.2M | 245K | 232.8K | |
| Total Cash From Operating Activities | (98.2M) | (131.8M) | (158.3M) | (178.8M) | (105.9M) | (111.2M) | |
| Change To Account Receivables | 747K | (529K) | (617K) | (7.7M) | 9.8M | 10.2M | |
| Net Income | 366.1M | 4.6M | (62.7M) | (37.1M) | (65.7M) | (62.4M) | |
| Total Cash From Financing Activities | 49.9M | 38.9M | 22.7M | (29.8M) | 78.1M | 47.9M | |
| End Period Cash Flow | 132.4M | 403.9M | 465.7M | 149.9M | 191.1M | 165.9M | |
| Investments | 63.7M | 369.6M | 217.6M | (107.2M) | 69.0M | 89.8M | |
| Net Borrowings | 6.0M | (250K) | 36.9M | (1.2M) | (1.3M) | (1.3M) | |
| Total Cashflows From Investing Activities | (39.6M) | 63.7M | 364.5M | 197.4M | 227.0M | 114.8M | |
| Change To Operating Activities | (438K) | 2.9M | (3.4M) | (5.5M) | (4.9M) | (4.7M) | |
| Change To Netincome | (41.9M) | (541.0M) | (135.9M) | (105.9M) | (95.3M) | (100.0M) | |
| Change To Liabilities | 4.5M | 9.9M | 11.4M | (4.6M) | 6.9M | 0.0 | |
| Issuance Of Capital Stock | 50.3M | 2.0M | 12.9M | 332K | 1.2M | 1.1M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether PureTech Health PLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of PureTech Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Puretech Health Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Puretech Health Plc Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PureTech Health PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PureTech Health. If investors know PureTech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PureTech Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.615 | Earnings Share (3.00) | Revenue Per Share 0.02 | Quarterly Revenue Growth (0.91) | Return On Assets (0.13) |
The market value of PureTech Health PLC is measured differently than its book value, which is the value of PureTech that is recorded on the company's balance sheet. Investors also form their own opinion of PureTech Health's value that differs from its market value or its book value, called intrinsic value, which is PureTech Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PureTech Health's market value can be influenced by many factors that don't directly affect PureTech Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PureTech Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if PureTech Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PureTech Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.